Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

NCT04765592 is registered in ClinicalTrials.gov with Hangzhou Endonom Medtech Co., Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04765592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)
Lead sponsor
Hangzhou Endonom Medtech Co., Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 7, 2021
Completion date
February 5, 2029
Enrollment
88 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

aortic arch aneurysm